During the past decade, Centre Val Aurelle Paul Lamarque; Medecine A1 A2 conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centre Val Aurelle Paul Lamarque; Medecine A1 A2" are "Gastric Cancer" (1 trials) and "Ovarian Cancer" (1 trials). Many other conditions were trialed in "Centre Val Aurelle Paul Lamarque; Medecine A1 A2" in a lesser frequency.

Most popular intervention types in "Centre Val Aurelle Paul Lamarque; Medecine A1 A2" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (1 trials), "Taxane" (1 trials), "liposomal doxorubicin" (1 trials), "paclitaxel" (1 trials) and "topotecan" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Val Aurelle Paul Lamarque; Medecine A1 A2" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Centre Val Aurelle Paul Lamarque; Medecine A1 A2". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Centre Val Aurelle Paul Lamarque; Medecine A1 A2, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Val Aurelle Paul Lamarque; Medecine A1 A2, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".